ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC33857-10mg |
|
195883-06-8 |
Omtriptolide
|
0 | C24H28O9 | |
GC33857-5mg |
|
195883-06-8 |
Omtriptolide
|
0 | C24H28O9 | |
GC33857-1mg |
|
195883-06-8 |
Omtriptolide
|
0 | C24H28O9 | |
GC33857-10mM(1mLinDMSO) |
|
195883-06-8 |
Omtriptolide
|
0 | C24H28O9 | |
GC33856-100mg |
|
4419-39-0 |
Beclometasone (Beclomethasone)
|
0 | C22H29ClO5 | |
GC33856-50mg |
|
4419-39-0 |
Beclometasone (Beclomethasone)
|
0 | C22H29ClO5 | |
GC33856-25mg |
|
4419-39-0 |
Beclometasone (Beclomethasone)
|
0 | C22H29ClO5 | |
GC33856-10mM(1mLinDMSO) |
|
4419-39-0 |
Beclometasone (Beclomethasone)
|
0 | C22H29ClO5 | |
GC33855-100mg |
|
52225-20-4 |
DL-α-Tocopherol acetate (Vitamin E acetate)
|
0 | C31H52O3 | |
GC33855-10mM(1mLinDMSO) |
|
52225-20-4 |
DL-α-Tocopherol acetate (Vitamin E acetate)
|
0 | C31H52O3 | |
GC33854-100mg |
|
1679-53-4 |
10-Hydroxydecanoic acid (NSC 15139)
|
0 | C10H20O3 | |
GC33853-50mg |
|
149682-77-9 |
Talabostat (PT100)
|
0 | C9H19BN2O3 | |
GC33853-10mg |
|
149682-77-9 |
Talabostat (PT100)
|
0 | C9H19BN2O3 | |
GC33853-5mg |
|
149682-77-9 |
Talabostat (PT100)
|
0 | C9H19BN2O3 | |
GC33852-50mg |
|
3615-24-5 |
Ramifenazone (Isopropylaminoantipyrine)
|
0 | C14H19N3O | |
GC33852-10mg |
|
3615-24-5 |
Ramifenazone (Isopropylaminoantipyrine)
|
0 | C14H19N3O | |
GC33851-100mg |
|
85187-37-7 |
Cloperastine fendizoate
|
0 | C40H38ClNO5 | |
GC33851-10mM(1mLinDMSO) |
|
85187-37-7 |
Cloperastine fendizoate
|
0 | C40H38ClNO5 | |
GC33850-25mg |
|
23827-91-0 |
[Des-Arg9]-Bradykinin acetate
|
0 | C46H65N11O12 | |
GC33850-5mg |
|
23827-91-0 |
[Des-Arg9]-Bradykinin acetate
|
0 | C46H65N11O12 | |